Clinical Trial Update: Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial evaluating mitoxantrone hydrochloride liposomes in combination with GDP for relapsed/refractory peripheral T-cell lymphoma is underway, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• GDP (GDP regimen)
• Mitoxantrone hydrochloride liposomes (mitoxantrone hydrochloride liposomes)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Treatment, Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN